13.7% with Wegovy ... Lilly at 1-800-LillyRx (1-800-545-5979). Zepbound injection is approved as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL in single-dose pen or single-dose ...

At 72 weeks, Zepbound met the primary endpoint and all five key secondary endpoints, demonstrating superiority compared to Wegovy ... (1-800-545-5979). Zepbound injection is approved as a 2.5 mg, 5 mg ...

Participants using Zepbound lost an average of 50.3 lbs (22.8 kg) and participants on Wegovy ... pen in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL injection. For more information ...

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy In key secondary endpoints, Zepbound was superior to Wegovy across all weight reduction targets and waist ...

During the trial, 6.1% of participants taking Zepbound discontinued treatment due to adverse events, compared to 8.0% of participants taking Wegovy ... mg, or 15 mg per 0.5 mL in single-dose pen ...

Participants achieved an average weight loss of 20.2% with Zepbound vs. 13.7% with Wegovy ...

Participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or 2.4 milligrams. By the end of the trial ...